Tag: pulmotech maa market growth

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Pulmotech MAA Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

The historical expansion was a result of the rising occurrence of pulmonary embolism cases, the broadening of nuclear medicine facilities in hospitals, the accessibility of technetium-based radiopharmaceuticals, an increase in diagnostic imaging processes, and the growing clinical endorsement of lung scintigraphy.

The anticipated growth during the forecast period stems from the escalating requirement for timely and precise pulmonary diagnostics, increased capital allocation towards nuclear medicine infrastructure, the broadening scope of clinical research involving radiotracers, a heightened concentration on personalized diagnostic imaging, and breakthroughs in imaging agent technology. Noteworthy trends throughout this period encompass the wider acceptance of advanced lung perfusion imaging agents, an increased utilization of nuclear medicine in pulmonary diagnostics, a greater need for accurate detection of pulmonary embolisms, the expansion of clinical applications for radiopharmaceuticals, and a reinforced emphasis on the accuracy and safety of imaging procedures.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=91756136&type=smp&name=Pulmotech%20MAA%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Pulmotech MAA Market Demand Drivers Opening New Revenue Streams

The rising incidence of respiratory illnesses is projected to fuel the expansion of the pulmotech MAA market in the coming period. Respiratory illnesses encompass diverse ailments impacting the lungs and other components of the respiratory system, specifically the airways, lungs, and associated muscles. The growing occurrence of respiratory diseases stems from a blend of environmental contaminants, lifestyle choices, an aging demographic, and improvements in diagnostic techniques. Pulmotech MAA serves in diagnosing and managing persistent respiratory ailments through assisting in pulmonary imaging, which evaluates localized lung function and identifies possible irregularities like perfusion deficits. For example, data from June 2024 published by the Australian Institute of Health and Welfare, an Australia-based health and welfare organization, estimated that around 8.5 million individuals in Australia, representing 34% of the populace, suffered from chronic respiratory conditions. This figure comprised an estimated 2.8 million people (11% of the population) affected by asthma and 638,000 individuals (2.5% of the population) afflicted with chronic obstructive pulmonary disease (COPD). Consequently, the expanding prevalence of respiratory diseases is propelling the pulmotech MAA market.

Pulmotech MAA Market Segment Landscape And Growth Outlook

The pulmotech maa market covered in this report is segmented –

1) By Application: Pulmonary Embolism Diagnosis, Preoperative Assessment, Lung Transplant Viability, Chronic Respiratory Disease Evaluation, Clinical Research

2) By Distribution Channel: Direct Sales, Distributors, Online Platforms

3) By End-User: Hospitals, Research Institutions, Diagnostic Imaging Centers

Pulmotech MAA Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the pulmotech maa market are Curium Pharma

View The Full Pulmotech MAA Market Report:

https://thebusinessresearchcompany.com/report/pulmotech-maa-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Pulmotech MAA Market Regional Analysis And Leading Geography

North America was the largest region in the pulmotech MAA market in 2025. The regions covered in the pulmotech maa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Pulmotech MAA Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

The historical growth was largely a result of the escalating prevalence of pulmonary embolism, alongside the expansion of nuclear medicine units in hospitals, the easy availability of technetium-based radiopharmaceuticals, an uptick in diagnostic imaging volumes, and the growing reliance on lung scintigraphy within clinical practice.

The anticipated expansion during the forecast period is driven by a heightened need for prompt and precise pulmonary diagnostics, along with greater funding for nuclear medicine facilities. It also stems from the broader application of radiotracers in clinical research, an escalating emphasis on tailored diagnostic imaging, and ongoing improvements in imaging agent technology. Key developments expected to shape this period include a growing preference for sophisticated lung perfusion imaging products, increased utilization of nuclear medicine techniques in diagnosing lung conditions, a surge in demand for reliable pulmonary embolism identification, the widening use of radiopharmaceuticals in clinical settings, and a stronger focus on enhancing both the precision and safety of imaging procedures.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20329&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

#Pulmotech MAA Market Growth Factors: Which Forces Are Supporting Market Expansion?

The anticipated rise in respiratory disease cases is set to foster growth in the pulmotech MAA market in the upcoming period. Respiratory diseases encompass a variety of disorders impacting the lungs and respiratory system, including the airways, lungs, and respiratory muscles. Factors such as environmental pollution, lifestyle choices, aging demographics, and improved diagnostic tools are contributing to the heightened occurrence of these conditions. Pulmotech MAA plays a role in diagnosing and handling chronic respiratory issues through enhanced pulmonary imaging, which evaluates regional lung function and identifies possible abnormalities like perfusion deficits. As an example, data from the Australian Institute of Health and Welfare, a health and welfare body based in Australia, revealed in June 2024 that roughly 8.5 million Australians, representing 34% of the population, were projected to have chronic respiratory conditions. This figure comprised about 2.8 million individuals, or 11% of the population, with asthma, and 638,000 people, or 2.5%, living with chronic obstructive pulmonary disease (COPD). Consequently, the growing frequency of respiratory diseases is fueling demand in the pulmotech MAA market.

The mounting incidence of chronic conditions is anticipated to spur advancement in the pulmotech MAA market moving forward. Chronic diseases are defined as health issues that endure over lengthy durations, frequently spanning years or a lifetime, and their rising prevalence stems mainly from shifts in lifestyle, older population segments, and environmental influences. Pulmotech MAA proves beneficial in addressing the escalating burden of chronic illnesses, especially those impacting the respiratory system. This technology aids in evaluating and handling chronic diseases via precise pulmonary perfusion imaging, which supports diagnosis of conditions like pulmonary embolism and monitoring of lung disorders. For instance, in April 2025, the National Center for Health Statistics (NCHS), part of the US-based Centers for Disease Control and Prevention (CDC), reported a growing trend in chronic diseases, particularly among younger and middle-aged adults. Obesity among young adults increased from 27.3% in 2023, while depression rates climbed from 25.0%, with diabetes and chronic kidney disease also rising in midlife groups. Hence, the expanding prevalence of chronic diseases is projected to propel the pulmotech MAA market forward.

The growth of the pulmotech MAA market in the coming years is expected to be driven by the expanding elderly population. An aging population refers to a demographic trend where the percentage of older individuals, typically those aged 65 and above, increases. This shift is fueled by longer life expectancies resulting from healthcare advancements, enhanced living standards, and more effective management of chronic illnesses. Pulmotech MAA supports this demographic by offering detailed pulmonary imaging for diagnosing and tracking age-related respiratory conditions, which enables timely and precise treatment strategies. For example, statistics from the Population Reference Bureau (PRB), a US-based nonprofit, indicated in January 2024 that the number of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase, with their share of the total population growing from 17% to 23%. As a result, the expanding aging population is propelling the pulmotech MAA market.

Pulmotech MAA Market Segment Performance And Strategic Opportunities

The pulmotech maa market covered in this report is segmented –

1) By Application: Pulmonary Embolism Diagnosis, Preoperative Assessment, Lung Transplant Viability, Chronic Respiratory Disease Evaluation, Clinical Research

2) By Distribution Channel: Direct Sales, Distributors, Online Platforms

3) By End-User: Hospitals, Research Institutions, Diagnostic Imaging Centers

Pulmotech MAA Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the pulmotech maa market are Curium Pharma

Access The Complete Pulmotech MAA Market Report:

https://www.thebusinessresearchcompany.com/report/pulmotech-maa-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pulmotech MAA Market Regional Distribution: Which Areas Drive Market Expansion?

North America was the largest region in the pulmotech MAA market in 2025. The regions covered in the pulmotech maa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Pulmotech MAA Market During The 2026–2030 Period?

Historically, this growth was primarily driven by a surge in pulmonary embolism cases, the expansion of nuclear medicine departments within healthcare facilities, the widespread availability of technetium-based radiopharmaceuticals, an increase in diagnostic imaging procedures, and the growing clinical adoption of lung scintigraphy.

During the forecast period, expansion is anticipated due to an escalating need for timely and precise pulmonary diagnostics, coupled with increased capital expenditure in nuclear medicine infrastructure, broader clinical investigation utilizing radiotracers, a heightened emphasis on individualized diagnostic imaging, and advancements in imaging agent technology. Key trends for the forecast period encompass a growing uptake of sophisticated lung perfusion imaging agents, an increased reliance on nuclear medicine for pulmonary diagnostics, a heightened requirement for accurate pulmonary embolism identification, the broadening scope of radiopharmaceutical clinical applications, and a stronger emphasis on ensuring imaging accuracy and patient safety.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20329&type=smp

What Key Growth Drivers Are Influencing The Pulmotech MAA Market?

The escalating occurrence of respiratory conditions is projected to boost the pulmotech MAA market. These conditions encompass a wide array of ailments affecting the lungs and other respiratory components like airways and muscles. The rising prevalence of respiratory diseases is influenced by factors such as environmental pollution, lifestyle choices, an aging populace, and enhancements in diagnostic techniques. Pulmotech MAA serves in the diagnosis and management of long-term respiratory issues by facilitating pulmonary imaging to evaluate regional lung function and identify potential anomalies like perfusion deficits. As an illustration, in June 2024, the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, reported that approximately 8.5 million people in Australia, representing 34% of the population, were estimated to be living with chronic respiratory conditions. This figure includes about 2.8 million individuals, or 11% of the population, with asthma, and 638,000 people, or 2.5% of the population, suffering from chronic obstructive pulmonary disease (COPD). Consequently, the increased incidence of respiratory diseases is fueling the pulmotech MAA market. The increasing prevalence of chronic diseases is set to drive the expansion of the pulmotech MAA market. Chronic diseases are defined as health conditions that persist for prolonged periods, often spanning years or a lifetime. This rise in chronic diseases is primarily attributed to shifts in lifestyle, an aging global population, and environmental factors. Pulmotech MAA offers significant utility in managing the escalating burden of chronic diseases, particularly those impacting the respiratory system. It is employed in the assessment and treatment of these conditions by enabling precise imaging of pulmonary perfusion, assisting in the diagnosis of ailments such as pulmonary embolism, and monitoring various lung disorders. For instance, in April 2025, the National Center for Health Statistics (NCHS) under the Centers for Disease Control and Prevention (CDC), a US-based source of health statistics, highlighted an upward trend in chronic diseases, notably among young and midlife adults. Among young adults, obesity prevalence saw an increase from 27.3% in 2023, and depression rose from 25.0%, alongside noted increases in diabetes and chronic kidney disease in midlife adults. Thus, the growing prevalence of chronic diseases is anticipated to spur the growth of the pulmotech MAA market.

How Is The Pulmotech MAA Market Distributed Across Key Segments?

The pulmotech maa market covered in this report is segmented –

1) By Application: Pulmonary Embolism Diagnosis, Preoperative Assessment, Lung Transplant Viability, Chronic Respiratory Disease Evaluation, Clinical Research

2) By Distribution Channel: Direct Sales, Distributors, Online Platforms

3) By End-User: Hospitals, Research Institutions, Diagnostic Imaging Centers

Which Companies Are Influencing The Pulmotech MAA Market?

Major companies operating in the pulmotech maa market are Curium Pharma

Access The Complete Pulmotech MAA Market Report:

https://www.thebusinessresearchcompany.com/report/pulmotech-maa-global-market-report

Which Geographic Region Represents The Largest Pulmotech MAA Market Share?

North America was the largest region in the pulmotech MAA market in 2025. The regions covered in the pulmotech maa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Pulmotech MAA Market In 2026 And 2030?

The historical period’s growth was primarily due to a rise in pulmonary embolism instances, the enlargement of hospital-based nuclear medicine units, the accessibility of technetium-derived radiopharmaceuticals, an increase in diagnostic imaging techniques, and enhanced clinical endorsement of lung scintigraphy.

Projected growth during the forecast period stems from the increasing demand for early and precise pulmonary diagnostics, rising investments in nuclear medicine infrastructure, the expansion of clinical research utilizing radiotracers, a growing emphasis on personalized diagnostic imaging, and technological progress in imaging agents. Concurrently, major trends expected in this period encompass the greater adoption of advanced lung perfusion imaging agents, an increased application of nuclear medicine in pulmonary diagnostics, a heightened demand for accurate pulmonary embolism detection, the expansion of radiopharmaceutical clinical uses, and an enhanced focus on imaging accuracy and patient safety.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20329&type=smp

What Key Factors Are Shaping The Pulmotech MAA Market Landscape?

The escalating occurrence of respiratory conditions is projected to boost the pulmotech MAA market. These conditions encompass a wide array of ailments affecting the lungs and other respiratory components like airways and muscles. The rising prevalence of respiratory diseases is influenced by factors such as environmental pollution, lifestyle choices, an aging populace, and enhancements in diagnostic techniques. Pulmotech MAA serves in the diagnosis and management of long-term respiratory issues by facilitating pulmonary imaging to evaluate regional lung function and identify potential anomalies like perfusion deficits. As an illustration, in June 2024, the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, reported that approximately 8.5 million people in Australia, representing 34% of the population, were estimated to be living with chronic respiratory conditions. This figure includes about 2.8 million individuals, or 11% of the population, with asthma, and 638,000 people, or 2.5% of the population, suffering from chronic obstructive pulmonary disease (COPD). Consequently, the increased incidence of respiratory diseases is fueling the pulmotech MAA market. The increasing prevalence of chronic diseases is set to drive the expansion of the pulmotech MAA market. Chronic diseases are defined as health conditions that persist for prolonged periods, often spanning years or a lifetime. This rise in chronic diseases is primarily attributed to shifts in lifestyle, an aging global population, and environmental factors. Pulmotech MAA offers significant utility in managing the escalating burden of chronic diseases, particularly those impacting the respiratory system. It is employed in the assessment and treatment of these conditions by enabling precise imaging of pulmonary perfusion, assisting in the diagnosis of ailments such as pulmonary embolism, and monitoring various lung disorders. For instance, in April 2025, the National Center for Health Statistics (NCHS) under the Centers for Disease Control and Prevention (CDC), a US-based source of health statistics, highlighted an upward trend in chronic diseases, notably among young and midlife adults. Among young adults, obesity prevalence saw an increase from 27.3% in 2023, and depression rose from 25.0%, alongside noted increases in diabetes and chronic kidney disease in midlife adults. Thus, the growing prevalence of chronic diseases is anticipated to spur the growth of the pulmotech MAA market.

Which Segments Define The Pulmotech MAA Market Segment Structure?

The pulmotech maa market covered in this report is segmented –

1) By Application: Pulmonary Embolism Diagnosis, Preoperative Assessment, Lung Transplant Viability, Chronic Respiratory Disease Evaluation, Clinical Research

2) By Distribution Channel: Direct Sales, Distributors, Online Platforms

3) By End-User: Hospitals, Research Institutions, Diagnostic Imaging Centers

Who Are The Established Players Within The Pulmotech MAA Market?

Major companies operating in the pulmotech maa market are Curium Pharma

Get The Full Pulmotech MAA Market Report:

https://www.thebusinessresearchcompany.com/report/pulmotech-maa-global-market-report

Which Region Represents The Largest Share Of The Pulmotech MAA Market?

North America was the largest region in the pulmotech MAA market in 2025. The regions covered in the pulmotech maa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pulmotech MAA Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pulmotech-maa-global-market-report

Browse Through More Reports Similar to the Global Pulmotech MAA Market 2026, By The Business Research Company

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Consumer Iam Market Report 2026

https://www.thebusinessresearchcompany.com/report/consumer-iam-global-market-report

Inductor Market Market Report 2026

https://www.thebusinessresearchcompany.com/report/inductor-market-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Pulmotech MAA Market By 2030 Starting From Its 2026 Size?

The expansion observed over the historical duration is attributable to a greater occurrence of pulmonary embolism incidents, the enlargement of nuclear medicine units in hospitals, the presence of technetium-derived radiopharmaceuticals, an escalation in diagnostic imaging processes, and the increasing medical adoption of lung scintigraphy.

Anticipated growth during the forecast period is fueled by an escalating need for timely and precise pulmonary diagnostics, increased capital expenditure in nuclear medicine infrastructure, an expansion of clinical investigations utilizing radiotracers, a heightened emphasis on individualized diagnostic imaging, and advancements in imaging agent technology. Key trends expected over the forecast horizon encompass a wider uptake of sophisticated lung perfusion imaging agents, an increased reliance on nuclear medicine for pulmonary diagnostics, a heightened necessity for precise pulmonary embolism identification, a broadening of radiopharmaceutical clinical uses, and a stronger commitment to the accuracy and safety of imaging procedures.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20329&type=smp

What Primary Drivers Are Shaping The Development Of The Pulmotech MAA Market?

The rising incidence of respiratory diseases is projected to stimulate the expansion of the pulmotech MAA market in the coming years. Respiratory diseases encompass a wide array of conditions impacting the lungs and other components of the respiratory system, including the airways, lung tissue, and respiratory muscles. The escalating occurrence of these illnesses is fueled by a combination of environmental pollutants, lifestyle choices, an aging populace, and enhancements in diagnostic methods. Pulmotech MAA is utilized to diagnose and manage chronic respiratory conditions by facilitating pulmonary imaging to evaluate regional lung function and identify potential irregularities such as perfusion deficits. For instance, in June 2024, data from the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, estimated that approximately 8.5 million people in Australia, or 34% of the population, were afflicted with chronic respiratory conditions. This total included an estimated 2.8 million individuals, or 11% of the population, living with asthma, and 638,000 people, or 2.5% of the population, suffering from chronic obstructive pulmonary disease (COPD). Consequently, the growing prevalence of respiratory diseases is propelling the pulmotech MAA market.

Which Segment Categories Define The Pulmotech MAA Market?

The pulmotech maa market covered in this report is segmented –

1) By Application: Pulmonary Embolism Diagnosis, Preoperative Assessment, Lung Transplant Viability, Chronic Respiratory Disease Evaluation, Clinical Research

2) By Distribution Channel: Direct Sales, Distributors, Online Platforms

3) By End-User: Hospitals, Research Institutions, Diagnostic Imaging Centers

Who Are The Top Companies Competing In The Pulmotech MAA Market?

Major companies operating in the pulmotech maa market are Curium Pharma

Read the full pulmotech maa market report here:

https://www.thebusinessresearchcompany.com/report/pulmotech-maa-global-market-report

How Does The Pulmotech MAA Market Perform Across Major Global Regions?

North America was the largest region in the pulmotech MAA market in 2025. The regions covered in the pulmotech maa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pulmotech MAA Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20329&type=smp

Browse Through More Reports Similar to the Global Pulmotech MAA Market 2026, By The Business Research Company

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Consumer Iam Market Report 2026

https://www.thebusinessresearchcompany.com/report/consumer-iam-global-market-report

Inductor Market Market Report 2026

https://www.thebusinessresearchcompany.com/report/inductor-market-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pulmotech maa market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Pulmotech MAA Market expected to reach by 2030?

Historically, this growth was primarily driven by a higher occurrence of pulmonary embolism cases, the expansion of nuclear medicine departments within hospitals, the improved availability of technetium-based radiopharmaceuticals, an increase in diagnostic imaging procedures, and the growing clinical acceptance of lung scintigraphy.

The projected growth throughout the forecast period stems from the increasing requirement for early and precise pulmonary diagnostics, greater investments in nuclear medicine infrastructure, the expansion of clinical research utilizing radiotracers, a heightened focus on personalized diagnostic imaging, and technological advancements in imaging agents. Prominent trends for this period include the wider adoption of advanced lung perfusion imaging agents, the rising application of nuclear medicine in pulmonary diagnostics, an escalating demand for accurate detection of pulmonary embolisms, the broadening of clinical applications for radiopharmaceuticals, and an enhanced emphasis on imaging accuracy and safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20329&type=smp

What Drivers Are Driving Adoption Within The Pulmotech MAA Market?

The rising incidence of respiratory illnesses is projected to fuel the expansion of the pulmotech MAA market in the future. These conditions encompass various ailments impacting the lungs and other components of the respiratory system, such as airways, lung tissue, and breathing muscles. Several factors contribute to the growing occurrence of respiratory diseases, including environmental contaminants, lifestyle choices, an aging global demographic, and improvements in diagnostic techniques. Pulmotech MAA serves in the diagnosis and management of long-term respiratory ailments, facilitating pulmonary imaging to evaluate localized lung function and identify possible irregularities like perfusion deficits. As an illustration, data from June 2024 by the Australian Institute of Health and Welfare, an Australian health and welfare body, estimated that about 8.5 million individuals in Australia, representing 34% of the populace, suffered from chronic respiratory conditions. This figure comprised roughly 2.8 million people, or 11% of the population, affected by asthma, and 638,000 people, equating to 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Consequently, the expanding occurrence of respiratory diseases is a key impetus for the pulmotech MAA market.

How Is The Pulmotech MAA Market Organized Into Various Segments?

The pulmotech maa market covered in this report is segmented –

1) By Application: Pulmonary Embolism Diagnosis, Preoperative Assessment, Lung Transplant Viability, Chronic Respiratory Disease Evaluation, Clinical Research

2) By Distribution Channel: Direct Sales, Distributors, Online Platforms

3) By End-User: Hospitals, Research Institutions, Diagnostic Imaging Centers

Who Are The Primary Competitors In The Global Pulmotech MAA Market?

Major companies operating in the pulmotech maa market are Curium Pharma

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pulmotech-maa-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Pulmotech MAA Market?

North America was the largest region in the pulmotech MAA market in 2025. The regions covered in the pulmotech maa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pulmotech MAA Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20329&type=smp

Browse Through More Reports Similar to the Global Pulmotech MAA Market 2026, By The Business Research Company

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Consumer Iam Market Report 2026

https://www.thebusinessresearchcompany.com/report/consumer-iam-global-market-report

Inductor Market Market Report 2026

https://www.thebusinessresearchcompany.com/report/inductor-market-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Pulmotech MAA Market Grown from 2024 to 2025?

Over the last few years, the Pulmotech MAA market has exhibited a growth of XX (HCAGR). It’s forecasted that the market will expand from $XX million in 2024 to $XX million in 2025, representing a Compound Annual Growth Rate (CAGR) of XX%. The expansion noted in the past can be credited to factors such as regulatory approvals and safety standards, enhancements in healthcare infrastructure, overall improved diagnostic accuracy and the adoption of non-invasive techniques, and progressive developments in the field of nuclear medicine.

What Growth Rate Is Anticipated for the Pulmotech MAA Market in the Coming Years?

The market size of Pulmotech MAA is projected to experience a compound annual growth rate (CAGR) of XX% in the coming years, raising its value to $XX million by 2029. This surge during the forecast span can be chiefly linked to a rise in instances of respiratory diseases, advancements in technology involving diagnostic imaging, developed healthcare investments in developing markets, escalating demand for non-invasive diagnostic methods, and the aging demographic. Noteworthy trends during this forecast duration include an uptick in hybrid imaging systems adoption, the extension of precision and personalized medicine, technological progress in radiopharmaceuticals, improvements in radiopharmaceuticals intended for sensitive and pediatric groups, and intensified concentration on research involving respiratory diseases.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20329&type=smp

Who Are the Leading Companies in the Pulmotech MAA Market?

Major companies operating in the pulmotech maa market are Curium Pharma

What Are the Key Drivers of the Pulmotech MAA Market?

The escalating incidence of respiratory illnesses is anticipated to spur the expansion of the pulmotech MAA market. Respiratory ailments encompass a wide variety of disorders that impact the lungs and other components of the respiratory system, such as the airways, lungs, and respiratory muscles. Growth in these diseases is fueled by the confluence of environmental pollutants, habits, the aging demographic, and advancements in diagnostic techniques. Pulmotech MAA plays a crucial role in the diagnosis and treatment of chronic respiratory diseases by facilitating pulmonary imaging to evaluate regional lung function and identify possible abnormalities such as perfusion deficits. For example, in June 2024, data from the Australian Institute of Health and Welfare disclosed that almost 8.5 million Australians, or 34% of the population, were projected to have chronic respiratory disorders. This statistic includes an estimated 2.8 million individuals, or 11% of the population, afflicted with asthma, and 638,000 individuals, or 2.5% of the population, suffering from chronic obstructive pulmonary disease (COPD). As such, the rise of respiratory illnesses is acting as a catalyst for the growth of the pulmotech MAA market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20329&type=smp

What Are the Key Market Segments in the Pulmotech MAA Industry?

The pulmotech maa market covered in this report is segmented –

1) By Application: Pulmonary Embolism Diagnosis; Preoperative Assessment; Lung Transplant Viability; Chronic Respiratory Disease Evaluation; Clinical Research

2) By Distribution Channel: Direct Sales; Distributors; Online Platforms

3) By End-User: Hospitals; Research Institutions; Diagnostic Imaging Centers

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pulmotech-maa-global-market-report

What Are the Key Regional Markets in the Pulmotech MAA Industry?

North America was the largest region in the pulmotech MAA market in 2024. The regions covered in the pulmotech maa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20329

This Report Delivers Insight On:

1. How big is the pulmotech maa market, and how is it changing globally?

2. Who are the major companies in the pulmotech maa market, and how are they performing?

3. What are the key opportunities and risks in the pulmotech maa market right now?

4. Which products or customer segments are growing the most in the pulmotech maa market?

5. What factors are helping or slowing down the growth of the pulmotech maa market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Has The Pulmotech MAA Market Size Shifted, And What Is the Outlook Through 2034?

In recent years, the market size of Pulmotech MAA has seen an HCAGR of XX. Forecasts show a rise from $XX million in 2024 to $XX million in 2025 with a Compound Annual Growth Rate (CAGR) of XX%. The growth experienced in the past can be connected to regulatory approvals and safety standards, developments in healthcare infrastructure, increasing accuracy in diagnostics and non-invasive methodologies, as well as advancements in the field of nuclear medicine.

In the forthcoming years, the pulmotech MAA market size is projected to witness XX (FCAGR). By 2029, it is anticipated to expand to $XX million, with a compound annual growth rate (CAGR) of XX%. The projected growth during the forecast period is linked to the escalating frequency of respiratory diseases, advancements in diagnostic imaging technology, increased health care investments in developing markets, a surge in demand for non-invasive diagnostic methods, and an aging population base. The forecast period will witness several key trends including a surge in the adoption of hybrid imaging systems, the proliferation of personalized and precision medicine, developments in radiopharmaceuticals, progress in radiopharmaceuticals for pediatric and sensitive groups, and heightened focus on respiratory disease research.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20329&type=smp

What are the Fundamental Drivers and Innovations Shaping the Pulmotech MAA Market?

The escalating incidence of respiratory ailments is anticipated to fuel the expansion of the pulmotech MAA market in the future. Respiratory illnesses cover a wide spectrum of disorders affecting the lungs and other components of the respiratory system, such as airways, lungs, and breathing muscles. The growing incidence of these illnesses is driven by a mix of environmental pollutants, lifestyle choices, aging demographics, and advancements in diagnostic procedures. Pulmotech MAA aids in diagnosing and managing persistent respiratory diseases by facilitating pulmonary imaging, which evaluates regional lung function and identifies possible anomalies like perfusion deficits. For instance, the Australian Institute of Health and Welfare reported in June 2024 that around 8.5 million individuals or 34% of the Australian population were estimated to be suffering from chronic respiratory diseases. This figure includes an estimated 2.8 million individuals, constituting 11% of the population, with asthma and 638,000 individuals or 2.5% of the population, with Chronic Obstructive Pulmonary Disease (COPD). Hence, the escalating prevalence of respiratory illnesses is propelling the growth of the pulmotech MAA market.

How Is the Pulmotech MAA Market Segmented?

The pulmotech maa market covered in this report is segmented –

1) By Application: Pulmonary Embolism Diagnosis; Preoperative Assessment; Lung Transplant Viability; Chronic Respiratory Disease Evaluation; Clinical Research

2) By Distribution Channel: Direct Sales; Distributors; Online Platforms

3) By End-User: Hospitals; Research Institutions; Diagnostic Imaging Centers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20329&type=smp

Which Regions Are Driving the Next Phase of the Pulmotech MAA Market Growth?

North America was the largest region in the pulmotech MAA market in 2024. The regions covered in the pulmotech maa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pulmotech-maa-global-market-report

How Is the Pulmotech MAA Market Defined and What Are Its Core Parameters?

Pulmotech MAA is a radiopharmaceutical agent used in lung scintigraphy to evaluate pulmonary perfusion. It consists of technetium Tc 99m-labeled aggregated human serum albumin particles, which, when injected intravenously, become temporarily lodged in the lung capillaries, allowing for imaging of blood flow in the lungs

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20329

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Pulmotech MAA Market?

The increasing prevalence of respiratory diseases is expected to propel the growth of the pulmotech MAA market going forward. Respiratory diseases refer to a broad range of conditions that affect the lungs and other parts of the respiratory system, which include the airways, lungs, and respiratory muscles. A combination of environmental pollutants, lifestyle factors, aging populations, and advancements in diagnostic methods drives the increasing prevalence of respiratory diseases. Pulmotech MAA is used to diagnose and manage chronic respiratory conditions by aiding in pulmonary imaging to assess regional lung function and detect potential abnormalities such as perfusion deficits. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, approximately 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people, or 11% of the population, living with asthma and 638,000 people, or 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Therefore, the increasing prevalence of respiratory diseases is driving the pulmotech MAA market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20329&type=smp

#What Long-Term Growth Rate is Expected for thePulmotech MAA Market Between 2025 and 2034?

The pulmotech MAA market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to regulatory approvals and safety standards, improved healthcare infrastructure, regulatory approvals, and safety standards, increasing diagnostic accuracy and non-invasive methods, and advancements in nuclear medicine.

The pulmotech MAA market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the increasing prevalence of respiratory diseases, technological advancements in diagnostic imaging, growing healthcare investments in emerging markets, rising demand for non-invasive diagnostic techniques, and the aging population. Major trends in the forecast period include increasing adoption of hybrid imaging systems, expansion of personalized and precision medicine, technological advancements in radiopharmaceuticals, advancements in radiopharmaceuticals for pediatric and sensitive populations, and increasing focus on respiratory disease research.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20329

Who Are the Leading Market Players Fueling Growth in the Pulmotech MAA Market Trend?

Major companies operating in the pulmotech maa market are Curium Pharma

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/pulmotech-maa-global-market-report

How is the Global Pulmotech MAA Market Segemented?

The pulmotech maa market covered in this report is segmented –

1) By Application: Pulmonary Embolism Diagnosis; Preoperative Assessment; Lung Transplant Viability; Chronic Respiratory Disease Evaluation; Clinical Research

2) By Distribution Channel: Direct Sales; Distributors; Online Platforms

3) By End-User: Hospitals; Research Institutions; Diagnostic Imaging Centers

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20329&type=smp

Which Geographics are Influencing the Growth of the Pulmotech MAA Market?

North America was the largest region in the pulmotech MAA market in 2024. The regions covered in the pulmotech maa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Pulmotech MAA Market 2025, By The Business Research Company:

Lung Cancer Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Lung Cancer Diagnostic And Screening Global Market Report 2025

https://thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

Small Cell Lung Cancer Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/small-cell-lung-cancer-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: